Omalizumab Subcutaneous and Orencia (Abatacept Infusion)
Determining the interaction of Omalizumab Subcutaneous and Orencia (Abatacept Infusion) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
Generic Name: abatacept
Brand name: Orencia, Orencia ClickJect, Orencia Prefilled Syringe
Synonyms: Orencia
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Omalizumab Subcutaneous-Orencia (Abatacept Prefilled Syringes)
- Omalizumab Subcutaneous-Orenitram
- Omalizumab Subcutaneous-Orfadin
- Omalizumab Subcutaneous-Orfadin (Nitisinone Capsules)
- Omalizumab Subcutaneous-Orfadin (Nitisinone Oral Suspension)
- Omalizumab Subcutaneous-Orfadin Suspension
- Orencia (Abatacept Infusion)-Ombitasvir, Paritaprevir, and Ritonavir
- Orencia (Abatacept Infusion)-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Orencia (Abatacept Infusion)-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Orencia (Abatacept Infusion)-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Orencia (Abatacept Infusion)-Omeclamox-Pak
- Orencia (Abatacept Infusion)-Omega-3 Fatty Acid Capsules